ArticleJournal for immunotherapy of cancer2023

Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.

Luke Frankiw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.